Phase I/II study of selective cyclooxygenase-2 inhibitor celecoxib as a radiation sensitizer in patients with unresectable brain metastases

Author: Cerchietti Leandro   Bonomi Marcelo   Navigante Alfredo   Castro Monica   Cabalar Maria   Roth Berta  

Publisher: Springer Publishing Company

ISSN: 0167-594X

Source: Journal of Neuro-Oncology, Vol.71, Iss.1, 2005-01, pp. : 73-81

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract